PT1297342E - Metodo de diagnostico para a doenca de alzheimer com base em holo-transcobalamina ii - Google Patents
Metodo de diagnostico para a doenca de alzheimer com base em holo-transcobalamina iiInfo
- Publication number
- PT1297342E PT1297342E PT01931928T PT01931928T PT1297342E PT 1297342 E PT1297342 E PT 1297342E PT 01931928 T PT01931928 T PT 01931928T PT 01931928 T PT01931928 T PT 01931928T PT 1297342 E PT1297342 E PT 1297342E
- Authority
- PT
- Portugal
- Prior art keywords
- holo
- alzheimer
- transcobalamin
- diagnosis
- disease based
- Prior art date
Links
- 208000024827 Alzheimer disease Diseases 0.000 title abstract 2
- 102000011409 Transcobalamins Human genes 0.000 title 1
- 108010023603 Transcobalamins Proteins 0.000 title 1
- 238000003745 diagnosis Methods 0.000 title 1
- 238000000034 method Methods 0.000 title 1
- 238000003556 assay Methods 0.000 abstract 1
- 210000001124 body fluid Anatomy 0.000 abstract 1
- 239000010839 body fluid Substances 0.000 abstract 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
- G01N33/6893—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids related to diseases not provided for elsewhere
- G01N33/6896—Neurological disorders, e.g. Alzheimer's disease
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/82—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving vitamins or their receptors
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N2800/00—Detection or diagnosis of diseases
- G01N2800/28—Neurological disorders
- G01N2800/2814—Dementia; Cognitive disorders
- G01N2800/2821—Alzheimer
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Molecular Biology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Physics & Mathematics (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Mechanical Treatment Of Semiconductor (AREA)
- Measuring And Recording Apparatus For Diagnosis (AREA)
- Devices For Conveying Motion By Means Of Endless Flexible Members (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GBGB0016460.8A GB0016460D0 (en) | 2000-07-04 | 2000-07-04 | Assay |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1297342E true PT1297342E (pt) | 2005-10-31 |
Family
ID=9895035
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT01931928T PT1297342E (pt) | 2000-07-04 | 2001-05-22 | Metodo de diagnostico para a doenca de alzheimer com base em holo-transcobalamina ii |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US7294514B2 (pt) |
| EP (1) | EP1297342B1 (pt) |
| JP (1) | JP2004502940A (pt) |
| AT (1) | ATE302416T1 (pt) |
| AU (1) | AU2001258614A1 (pt) |
| DE (1) | DE60112758T2 (pt) |
| DK (1) | DK1297342T3 (pt) |
| ES (1) | ES2249432T3 (pt) |
| GB (1) | GB0016460D0 (pt) |
| PT (1) | PT1297342E (pt) |
| WO (1) | WO2002003074A1 (pt) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20150065449A1 (en) | 2011-08-12 | 2015-03-05 | Florida State University Research Foundation, Inc. | Treating Amyloidoses With A Vitamin B12 Composition Including Melatonin, Resveratrol, and EGCG |
| WO2018188771A1 (en) * | 2017-04-11 | 2018-10-18 | Nestec S.A. | Omega-3 fatty acid and vitamin d levels to identify and attenuate cognitive aging in individuals |
| MX2019010484A (es) * | 2017-04-11 | 2019-10-17 | Nestle Sa | Niveles de acidos grasos omega-3 y vitamina d para identificar y atenuar el envejecimiento congnitivo en individuos. |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4273757A (en) * | 1977-06-02 | 1981-06-16 | Yissum Research Development Company | Determination of transcobalamins |
| US4680273A (en) * | 1985-07-29 | 1987-07-14 | Victor Herbert | Assay for vitamin B12 deficiency |
| EP1105739A1 (en) * | 1998-08-20 | 2001-06-13 | Axis-Shield Asa | Assay method for cardiovascular disease |
| GB9820473D0 (en) * | 1998-09-18 | 1998-11-11 | Axis Biochemicals Asa | Assay |
-
2000
- 2000-07-04 GB GBGB0016460.8A patent/GB0016460D0/en not_active Ceased
-
2001
- 2001-05-22 US US10/332,041 patent/US7294514B2/en not_active Expired - Lifetime
- 2001-05-22 AU AU2001258614A patent/AU2001258614A1/en not_active Abandoned
- 2001-05-22 EP EP01931928A patent/EP1297342B1/en not_active Expired - Lifetime
- 2001-05-22 AT AT01931928T patent/ATE302416T1/de not_active IP Right Cessation
- 2001-05-22 PT PT01931928T patent/PT1297342E/pt unknown
- 2001-05-22 JP JP2002508085A patent/JP2004502940A/ja not_active Withdrawn
- 2001-05-22 DE DE60112758T patent/DE60112758T2/de not_active Expired - Fee Related
- 2001-05-22 ES ES01931928T patent/ES2249432T3/es not_active Expired - Lifetime
- 2001-05-22 DK DK01931928T patent/DK1297342T3/da active
- 2001-05-22 WO PCT/GB2001/002306 patent/WO2002003074A1/en not_active Ceased
Also Published As
| Publication number | Publication date |
|---|---|
| ES2249432T3 (es) | 2006-04-01 |
| DE60112758D1 (de) | 2005-09-22 |
| US20040014230A1 (en) | 2004-01-22 |
| EP1297342B1 (en) | 2005-08-17 |
| JP2004502940A (ja) | 2004-01-29 |
| EP1297342A1 (en) | 2003-04-02 |
| GB0016460D0 (en) | 2000-08-23 |
| WO2002003074A1 (en) | 2002-01-10 |
| US7294514B2 (en) | 2007-11-13 |
| DE60112758T2 (de) | 2006-06-29 |
| ATE302416T1 (de) | 2005-09-15 |
| DK1297342T3 (da) | 2005-12-19 |
| AU2001258614A1 (en) | 2002-01-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69928809D1 (de) | Differentielle diagnose von neurodegeneration | |
| GB0510943D0 (en) | Improved immunoassay methods | |
| BR0206604A (pt) | Dispositivo de lanceta que tem ação capilar | |
| ATE283485T1 (de) | Verfahren zur diagnose und zur charakterisierung von schlaganfall | |
| BR0209262A (pt) | Processo para diagnóstico diferencial de demência de alzheimer e kit para o mesmo | |
| ATE337413T1 (de) | Methoden zur verbesserung der sensitivität und spezifität von screeningverfahren für krebs und krebs-vorstufen | |
| EP2251695A3 (en) | Markers associated with endometrial disease | |
| WO2002102229A3 (en) | Diagnosing tumorigenicity and determining resistance to anticancer therapy | |
| AU2003259222A1 (en) | Method of diagnosing alzheimer's disease | |
| WO2007016367A3 (en) | Neoplastic disease-related methods, kits, systems and databases | |
| BR0314155A (pt) | Métodos para diagnosticar câncer cervical | |
| BR0109915A (pt) | Teste de diagnóstico para doença de alzheimer | |
| CY1106688T1 (el) | Αποτιμηση κοβαλαμινης | |
| WO2007030949A3 (en) | Methods of diagnosing ovarian cancer and kits therefor | |
| ATE275268T1 (de) | Verfahren zur diagnose von sjögren-syndrom | |
| ATE420365T1 (de) | Präparierung von sphären für diagnostische tests | |
| DK1297342T3 (da) | Metode til diagnostisk bestemmelse af Alzheimer's sygdom på basis af holo-transcobalamin II | |
| BR0007702A (pt) | Método e kit de diagnóstico para diagnose de endometriose | |
| BRPI0415562A (pt) | reagente para avaliação diagnóstica e/ou prognóstica de carcinoma, métodos para determinação de p-lap que é um fator prognóstico em carcinoma, e para avaliação prognóstica de carcinoma, e, kit de imunoensaio para determinação da quantidade de p-lap presente em tecidos de carcinoma | |
| ATE459877T1 (de) | Diagnostikum für die frühe phase von morbus alzheimer | |
| DE69912453D1 (de) | Verfahren und materialien zur diagnose instabiler angina | |
| EP1896849A4 (en) | ANTIBODIES TO HISTONE MODIFICATIONS FOR CLINICAL CANCER DIAGNOSIS AND PROGNOSIS | |
| EP1567045A4 (en) | METHOD FOR DIAGNOSING THE PRESENT OR BZW. STADIUM OF CANCER | |
| DE60237406D1 (de) | Aus einem Neuroblastom isolierte Nukleinsäuren | |
| WO2002044723A3 (en) | Method for diagnosing a predisposition of psychosis in a progeny |